Zobrazeno 41 - 50
of 121
pro vyhledávání: '"Julianne Chen"'
Autor:
Rohtesh S. Mehta, Amin M. Alousi, Muzaffar H. Qazilbash, Keyur P. Patel, Ankur Varma, Julianne Chen, Richard R. Champlin, Piyanuch Kongtim, Qaiser Bashir, Sa A. Wang, Samer A. Srour, Omar Hasan, Issa F. Khouri, Jorge M. Ramos Perez, Partow Kebriaei, Stefan O. Ciurea, Gabriela Rondon, Elizabeth J. Shpall, Uday R. Popat
Publikováno v:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 26(1)
Molecular data and minimal residual disease (MRD) have been shown to influence outcomes in acute myeloid leukemia (AML) patients undergoing allogeneic hematopoietic cell transplantation (AHCT). Here we developed and validated a novel AML-specific dis
Autor:
Julianne Chen, Rui Yu Wang, Zhihong Zeng, Richard E. Champlin, Hongbo Lu, Christopher B. Benton, Marina Konopleva, Wenbin Liu, Sergej Konoplev, Keith A. Baggerly, Elizabeth J. Shpall
Publikováno v:
Acta Haematol
To characterize intracellular signaling in peripheral blood (PB) cells of acute myeloid leukemia (AML) patients undergoing pretransplant conditioning with CXCR4 inhibitor plerixafor, granulocyte colony-stimulating factor (G-CSF), and busulfan plus fl
Autor:
Indreshpal Kaur, Elizabeth J. Shpall, Tobi Fisher, Gabriela Rondon, Marcelo Fernandez-Vina, Julianne Chen, Kai Cao, Dean A. Lee, Glenda Woodworth, Cecele J. Denman, Stefan O. Ciurea, Richard E. Champlin
Publikováno v:
Biology of Blood and Marrow Transplantation. 22:1290-1298
Allogeneic stem cell transplantation is an effective treatment for high-risk myeloid malignancies, but relapse remains the major post-transplantation cause of treatment failure. Alloreactive natural killer (NK) cells mediate a potent antileukemic eff
Autor:
Aimee E. Hammerstrom, Stefan O. Ciurea, Uday R. Popat, Muzaffar H. Qazilbash, Gabriela Rondon, Rima M. Saliba, Sairah Ahmed, Julianne Chen, Chitra Hosing, Richard E. Champlin, Amin M. Alousi, Qaiser Bashir, Issa F. Khouri, Elizabeth J. Shpall, Rohtesh S. Mehta
Publikováno v:
British Journal of Haematology. 173:444-455
Post-transplantation cyclophosphamide (PTCy) is an effective strategy to prevent graft-versus-host disease (GVHD) after haploidentical haematopoietic cell transplantation (HCT). We determined the efficacy of PTCy-based GVHD prophylaxis in human leuco
Autor:
Julianne Chen, Gheath Alatrash, Richard E. Champlin, Stefan O. Ciurea, Katayoun Rezvani, Gabriela Rondon, Denái R. Milton, Ulas D. Bayraktar, Michele Guindani
Publikováno v:
Biology of Blood and Marrow Transplantation. 22:505-513
PURPOSE: The recovery pace of absolute lymphocyte count (ALC) is prognostic after hematopoietic stem cell transplantation (SCT). Previous studies have evaluated a wide range of ALC cutoffs and time points to predict outcomes. We aimed to determine th
Autor:
Elizabeth J. Shpall, Betul Oran, Partow Kebriaei, Stefan O. Ciurea, Gheath Alatrash, L. Jeffrey Medeiros, Julianne Chen, Richard E. Champlin, Rima M. Saliba, Hans C. Lee, Uday R. Popat, Yasmeen Charafeddine, Gabriela Rondon, Borje S. Andersson
Publikováno v:
Biology of Blood and Marrow Transplantation. 21:1948-1954
Chimerism testing after allogeneic hematopoietic stem cell transplantation (allo-HSCT) in patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) represents a promising tool for predicting disease relapse, although its precise
Autor:
Jin Seon Im, Samer A. Srour, Betul Oran, Julianne Chen, Denái R. Milton, Amanda Olson, Borje S. Andersson, May Daher, Stefan O. Ciurea, Amin M. Alousi, Neeraj Saini, Gheath Alatrash, Richard E. Champlin, Rohtesh S. Mehta, Jacinth Joseph, Qaiser Bashir, Uday R. Popat
Publikováno v:
Journal of Clinical Oncology. 38:e19520-e19520
e19520 Background: Scoring systems, such as DIPSS-plus, prognosticate outcomes of myelofibrosis (MF) at diagnosis and at transplant. In this study, we evaluated the impact of individual components of these scoring systems, along with other factors pr
Autor:
Glenda Woodworth, Becky McMullin, Julianne Chen, Paolo Anderlini, Richard E. Champlin, David Marin, Katayoun Rezvani, Amin M. Alousi, Neeraj Saini, Issa F. Khouri, Qaiser Bashir, Uday R. Popat, Rima M. Saliba, Jin Seon Im, Gheath Alatrash, Chitra Hosing, Muzaffar H. Qazilbash, Samer A. Srour, Rohtesh S. Mehta, Elizabeth J. Shpall, Amanda Olson, Partow Kebriaei, Stefan O. Ciurea, Borje S. Andersson, Yago Nieto, Betul Oran, Jeffrey J. Molldrem, Christina Ganesh
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:S125
Background Myeloablative conditioning can be given safely to older patients by simply administering busulfan over a longer period (fractionated busulfan regimen) than the standard four day regimen. (Popat et al Lancet Haematology 2018). Subsequently,
Autor:
Richard E. Champlin, Amanda Olson, Betul Oran, Rohtesh S. Mehta, Samer A. Srour, Marina Konopleva, Piyanuch Kongtim, Uday R. Popat, Julianne Chen, Amin M. Alousi, Gabriela Rondon, Ankur Varma, Qaiser Bashir, Chitra Hosing, Stefan O. Ciurea
Publikováno v:
Blood. 134:42-42
Introduction Allogeneic hematopoietic stem cell transplantation (AHSCT) is increasingly performed for older patients with AML; however, the optimal conditioning regimen for these patients remains unclear. Methods: We retrospectively evaluated outcome
Autor:
Jeffrey J. Molldrem, Julianne Chen, Jin S. Im, Issa F. Khouri, Gabriela Rondon, Partow Kebriaei, Amin M. Alousi, Amanda Olson, Chitra Hosing, Betul Oran, Glenda Woodworth, Paolo Anderlini, Stefan O. Ciurea, Samer A. Srour, Borje S. Andersson, Yago Nieto, Katayoun Rezvani, Qaiser Bashir, Rima M. Saliba, Christina Ganesh, Uday R. Popat, Elizabeth J. Shpall, David Marin, Muzaffar H. Qazilbash, Becky McMullin, Gheath Alatrash, Rohtesh S. Mehta, Neeraj Saini, Richard E. Champlin
Publikováno v:
Blood. 134:3296-3296
Background: Myeloablative conditioning can be given safely to older patients by simply administering busulfan over a longer period (fractionated busulfan regimen) than the standard four day regimen. (Popat et al Lancet Haematology 2018). Subsequently